Assessing the Safety and Tolerability of NMN in DHDDS-CDG

Clinical trial NCT07572825 · RECRUITING

Trial details

NCT number: NCT07572825
Sponsor: Eva Morava-Kozicz
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

DHDDS-Congenital Disorder of Glycosylation DHDDS-CDG Congenital Disorder of Glycosylation

Start date: 2026-05-08
Primary completion: 2027-08-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.